Our findings reveal that TAM resistance is associated with upregulation of FOXM1 and with a FOXM1-dependent gene expression program that enhances cell proliferation and invasiveness and elicits an increase in the proportion of CSCs within the breast cancer cell population. The gene discussed is FOXM1; the disease is breast cancer.